dexmedetomidine has been researched along with Cytokine Release Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davies, R; Ma, D; Zhao, H | 1 |
1 other study(ies) available for dexmedetomidine and Cytokine Release Syndrome
| Article | Year |
|---|---|
Potential therapeutic value of dexmedetomidine in COVID-19 patients admitted to ICU.
Topics: Adrenergic alpha-2 Receptor Agonists; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Dexmedetomidine; Female; Humans; Hypoxia; Intensive Care Units; Male; Patient Admission | 2021 |